Latest Antimicrobial peptides Stories
The ever-increasing threat from "superbugs" -- strains of pathogenic bacteria that are impervious to the antibiotics that subdued their predecessor generations -- has forced the medical community to look for bactericidal weapons outside the realm of traditional drugs.
Announcement comes on the first day of the North American Cystic Fibrosis Conference, where the latest data on N8's patented biopharmaceutical will be presented. Columbus,
A new study by Rice University biophysicists offers the most comprehensive picture yet of the molecular-level action of melittin, the principal toxin in bee venom.
Biologists at UC San Diego have identified eight genes never before suspected to play a role in wound healing that are called into action near the areas where wounds occur.
Cancer researchers from Rice University suggest that a new man-made drug that's already proven effective at killing cancer and drug-resistant bacteria could best deliver its knockout blow when used in combination with drugs made from naturally occurring toxins.
The immune system of the giant panda could help scientists develop new treatment for drug-resistant superbugs and other types of diseases, researchers have discovered.
For the first time, researchers have designed and created a membrane-bounded vesicle formed entirely of peptides -- molecules made up of amino acids, the building blocks of protein.
Exposed tissue surfaces, including skin and mucous membranes, are under constant threat of attack by microorganisms in the environment.
Human defensins, aptly named antimicrobial peptides, are made in immune system cells and epithelial cells (such as skin cells and cells that line the gut).
For 50 years scientists have been unsure how the bacteria that gives humans cholera manages to resist one of our basic innate immune responses.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.